1. Home
  2. CCII vs NAGE Comparison

CCII vs NAGE Comparison

Compare CCII & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CCII

Cohen Circle Acquisition Corp. II Class A Ordinary Shares

N/A

Current Price

$10.22

Market Cap

355.4M

Sector

N/A

ML Signal

N/A

Logo Niagen Bioscience Inc.

NAGE

Niagen Bioscience Inc.

HOLD

Current Price

$4.83

Market Cap

350.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCII
NAGE
Founded
2024
1999
Country
United States
United States
Employees
N/A
117
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
355.4M
350.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CCII
NAGE
Price
$10.22
$4.83
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$16.00
AVG Volume (30 Days)
87.1K
600.5K
Earning Date
01-01-0001
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$16.51
Revenue Next Year
N/A
$14.58
P/E Ratio
N/A
$21.29
Revenue Growth
N/A
N/A
52 Week Low
$10.07
$4.16
52 Week High
$10.47
$14.66

Technical Indicators

Market Signals
Indicator
CCII
NAGE
Relative Strength Index (RSI) 33.59 51.18
Support Level $10.19 $4.73
Resistance Level $10.29 $5.32
Average True Range (ATR) 0.01 0.20
MACD -0.00 0.01
Stochastic Oscillator 16.67 30.58

Price Performance

Historical Comparison
CCII
NAGE

About CCII Cohen Circle Acquisition Corp. II Class A Ordinary Shares

Cohen Circle Acquisition Corp II is a blank check company.

About NAGE Niagen Bioscience Inc.

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

Share on Social Networks: